Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Cdn_clipperon Jun 03, 2016 4:32pm
196 Views
Post# 24933013

RE:BIOAF VOLUME UP TO 25 k

RE:BIOAF VOLUME UP TO 25 kI trade on the cdn venture exchange.  The trading has been reasonably consistent over the last little while, with a slow drift upwards in the share price.   It almost looks as if it is being kept in this range as there is a usually a bit of an overhang.   I don't usually trade in biotechs, but was very intrigued after reading the Canadian National Post imterview with Rob Hutchinson.  This article combined with the very insightful posts by jdstox, my own browsing around and the recently announced collaboration with Astellas convinced me to invest at around the 1.35 range.   I wonder what the recent firming up over the last few days portends, if anything?  Be interesting to see what unfolds in the next few months.  CC
Bullboard Posts